Ignite Creation Date:
2024-07-17 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06477523
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-06-19
Brief Title:
Phase 1b2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC
Sponsor:
Sichuan University
Organization:
Sichuan University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-19
First Submit QC Date:
None
Study First Post Date:
2024-06-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-26
Last Update Post Date:
2024-06-27
Last Update Post Date Type:
ACTUAL